We are live on ! Find out more
GFP

Gryphon Financial Partners Portfolio holdings

AUM $1.13B
1-Year Est. Return 30.28%
This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+30.28%
3 Year Est. Return
+93.72%
5 Year Est. Return
+108.5%
10 Year Est. Return
AUM
$412M
AUM Growth
-$79.1M
Cap. Flow
-$9.49M
Cap. Flow %
-2.3%
Top 10 Hldgs %
59.48%
Holding
257
New
61
Increased
108
Reduced
51
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 9.03%
2 Technology 8.62%
3 Communication Services 6.92%
4 Industrials 6.23%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRSH
176
Marsh
MRSH
$91.4B
$203K 0.05%
+1,312
New +$210K
GM icon
177
General Motors
GM
$76.9B
$202K 0.05%
6,356
-1,248
-16% -$46.8K
IEFA icon
178
iShares Core MSCI EAFE ETF
IEFA
$194B
$199K 0.05%
3,369
-90
-3% -$5.77K
DFAT icon
179
Dimensional US Targeted Value ETF
DFAT
$14.7B
$196K 0.05%
4,876
RSPT icon
180
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.78B
$195K 0.05%
8,250
SDY icon
181
State Street SPDR S&P Dividend ETF
SDY
$23.8B
$185K 0.04%
+1,555
New +$194K
SNAP icon
182
Snap
SNAP
$8.78B
$185K 0.04%
14,088
-218
-2% -$4.97K
XBI icon
183
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$178K 0.04%
2,400
+65
+3% +$4.88K
IJJ icon
184
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.96B
$167K 0.04%
+1,769
New +$180K
BLFS icon
185
BioLife Solutions
BLFS
$1.66B
$164K 0.04%
11,839
+20
+0.2% +$293
AEO icon
186
American Eagle Outfitters
AEO
$2.97B
$151K 0.04%
13,568
+243
+2% +$3.43K
USIG icon
187
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$132K 0.03%
+2,583
New +$135K
ABCL icon
188
AbCellera Biologics
ABCL
$1.93B
$131K 0.03%
12,340
+1,850
+18% +$15.7K
FMTX
189
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$131K 0.03%
+18,993
New +$133K
DFUV icon
190
Dimensional US Marketwide Value ETF
DFUV
$15.7B
$129K 0.03%
+4,083
New +$136K
ONEM
191
DELISTED
1Life Healthcare
ONEM
$127K 0.03%
16,207
OEF icon
192
iShares S&P 100 ETF
OEF
$20.4B
$114K 0.03%
+659
New +$123K
VPU
193
Vanguard Utilities ETF
VPU
$8.33B
$106K 0.03%
+695
New +$109K
IBB icon
194
iShares Biotechnology ETF
IBB
$9.5B
$84K 0.02%
+714
New +$84.8K
XLV icon
195
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$75K 0.02%
+585
New +$76.7K
RSP icon
196
Invesco S&P 500 Equal Weight ETF
RSP
$98.9B
$73K 0.02%
+541
New +$79.2K
SGOV icon
197
iShares 0-3 Month Treasury Bond ETF
SGOV
$100B
$61K 0.01%
+609
New +$60.9K
USMV icon
198
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
$61K 0.01%
+873
New +$63.9K
IWR icon
199
iShares Russell Mid-Cap ETF
IWR
$56.9B
$55K 0.01%
+848
New +$60.4K
IYK icon
200
iShares US Consumer Staples ETF
IYK
$1.41B
$55K 0.01%
+840
New +$56.5K

Similar funds

Gryphon Financial Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Gryphon Financial Partners held 257 positions worth $412M, down 16% from $491M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Gryphon Financial Partners's Q2 2022 filing shows 61 new, 108 increased, 51 reduced and 20 closed positions. Its largest new stake was Warner Bros: 1,086,791 shares worth $14.6M. The largest sale was Discovery, Inc. Series C Common Stock, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 9% of assets, up from 8.1% a quarter earlier, followed by Technology and Communication Services.

  • Gryphon Financial Partners's largest Q2 2022 buy was Warner Bros: 1,086,791 shares worth $14.6M.
  • Gryphon Financial Partners added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $1.98M increase.
  • Gryphon Financial Partners's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38M.
  • Gryphon Financial Partners fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $26.9M.
  • Gryphon Financial Partners's ten largest holdings make up 59% of its $412M portfolio in Q2 2022.
  • Gryphon Financial Partners opened 61 new positions and closed 20 in Q2 2022.
  • Gryphon Financial Partners's portfolio value fell 16% quarter-over-quarter to $412M.

Based on Gryphon Financial Partners's 13F filing for Q2 2022, filed 28 Jul 2022.